Quarterly report pursuant to Section 13 or 15(d)

COMMON STOCK WARRANTS

v2.4.0.6
COMMON STOCK WARRANTS
9 Months Ended
Jun. 30, 2012
Common Stock Warrants  
COMMON STOCK WARRANTS
NOTE 8 – COMMON STOCK WARRANTS
 
For all warrants included within permanent equity, the Company has determined the estimated value of the warrants granted to non-employees in exchange for services and financing expenses using the Black-Scholes pricing model and the following assumptions: stock price at valuation, $0.21-$0.84; expected term of 3-5 years, exercise price of $0.50-$1.20, a risk free interest rate of 0.21-2.90 percent, a dividend yield of 0 percent and volatility of 114-276 percent. All warrants accounted for as a derivative liability have been valued using a Lattice Model as described in Note 6.
  
In connection with the January 15, 2010 financing, the Company issued 5,583,336 Class H warrants to the Series F warrant holders who exercised their Series F warrants. The Class H Warrants have a 5 year term with a strike price of $0.55. These warrants were originally determined to be a derivative liability but as of January 15, 2012, have been reclassified to permanent equity (see Note 6).
 
On April 9, 2010 the Company granted 10,000 warrants as payment for an outstanding accounts payable balance of $3,991.
 
On June 22, 2010 the Company authorized the issuance of 93,000 warrants for services to the Company.  Of these authorized warrants, 90,000 were issued on June 23, 2010 once the contract for services was finalized. These warrants have a 5 year term with a strike price of $0.50. The remaining 3,000 warrants were issued September 2, 2010. These warrants have a three year term with a strike price of $0.50.  The combined value of these warrants was $41,129 at the time of issuance and the value was expensed as research and development expense.
 
In connection with the December 30, 2010 financing, the investors received 2,520,000 Class I five year warrants to purchase common stock at an exercise price of $0.55 per share. The exercise price of these warrants contains certain reset provisions which require the fair value of the warrants to be reported as a liability and not in permanent equity. On the date of issuance, the Company calculated the fair value of these warrants to be $528,847. The total cash proceeds of $1,050,000 were first applied to the warrants with the remaining $521,153 being allocated to the common shares and being recorded in additional paid-in capital.
 
Between May 12 and August 23, 2011, the Company issued a total of 625,000 warrants for services rendered to the Company.  As of June 30, 2012, 495,000 warrants with a fair value of $296,753 had vested. During the nine months ended June 30, 2012, the Company recorded an expense of $54,014 to professional fees and $119,698 to research and development expense related to warrants vested during the period. An additional 100,000 warrants expired unvested during the nine months ended June 30, 2012.
 
In connection with the December 16, 2011 financing, the investors received 916,678 Class J five year warrants to purchase common stock at an exercise price of $0.65 per share.  On the date of issuance, the Company calculated the relative fair value of these warrants to be $314,453.

On March 3, 2012, the Company issued a total of 350,000 fully-vested warrants with a fair market value of $220,422 as a retainer for services to be rendered to the Company.  In accordance with ASC 505-50-25, the Company recorded the fair market value of the warrants as a prepaid expense to be amortized over the one year requisite service period. As of June 30, 2012, the Company has amortized $71,864 to professional fees.

On April 12, 2012, the Company issued a total of 15,000 fully-vested warrants with a fair market value of $12,775 as a retainer for services to be rendered to the Company.  In accordance with ASC 505-50-25, the Company recorded the fair market value of the warrants as a prepaid expense to be amortized over the 120 day requisite service period. As of June 30, 2012, the Company has amortized $11,214 to professional fees.

On May 18, 2012, the Company issued a total of 350,000 warrants to members of its scientific advisory board, with a fair market value of $314,469 for services yet to be rendered to the Company.  The warrants vest in two equal amounts, three and six months from the date of issuance.  As of June 30, 2012, the Company has not received any services related to these warrants and none have vested.  The value of the warrants will be recognized in expense as services are provided, which the Company believes will begin once the first tranche vests.

On June 28, 2012, the Company issued 3,179,410 replacement warrants under an incentive provision offered to investors who converted their series H warrants.  The warrants were valued at $2,663,204.  As the original warrants were issued as part of cash financing, the value of these warrants has been included as an offsetting entry within additional paid-in capital.
 
Below is a table summarizing the warrants issued and outstanding as of June 30, 2012.
 
Date
 
Number
   
Exercise
   
Contractual
   
Expiration
   
Value if
 
Issued
 
Outstanding
   
Price
   
Life (Years)
   
Date
   
Exercised
 
Balance 10/1/08
    13,509,857       1.18       5    
Various
      15,941,631  
03/20/09
    5,000,000       0.50       5    
03/31/14
      2,500,000  
06/03/09
    11,166,672       0.18       5    
06/03/14
      2,010,001  
09/30/09
    150,000       0.40       5    
06/30/14
      60,000  
Expired
    -       -       -       -       -  
Balance 9/30/09
    29,826,529       0.69       -       -       20,511,632  
10/09/09
    88,000       0.50       5    
10/29/14
      44,000  
11/09/09
    18,000       0.50       5    
11/09/14
      9,000  
12/04/09
    130,000       0.60       2    
12/04/11
      78,000  
12/15/09
    (5,583,336 )     0.18       -       -       (1,005,000 )
01/15/10
    5,583,336       0.55       5    
01/15/15
      3,070,835  
01/15/10
    (5,583,336 )     0.18       -       -       (1,005,000 )
04/09/10
    10,000       0.55       5    
4/9/2015
      5,500  
07/23/10
    93,000       0.50       3    
07/23/13
      46,500  
Expired
    -       -       -       -       -  
Balance 9/30/10
    24,582,193       0.89       -       -       21,755,467  
12/30/10
    2,520,000       0.55       5    
12/30/15
      1,386,000  
05/12/11
    55,000       0.50       5    
05/12/16
      27,500  
06/13/11
    300,000       0.50       2    
06/13/13
      150,000  
07/15/11
    100,000       0.54       5    
07/15/16
      54,000  
07/15/11
    120,000       0.54       2    
07/15/13
      64,800  
08/23/11
    50,000       0.67       3    
08/23/14
      33,500  
Expired
    (1,090,568 )     1.19       -       -       (1,297,776 )
Balance 9/30/11
    26,636,625       0.83       -       -       22,173,491  
12/16/11
    916,678       0.65       5    
12/16/16
      595,841  
03/03/12
    350,000       0.65       5    
03/03/17
      227,500  
04/11/12           (43,392 )     0.60       -     -       (26,035 )
04/12/12
    15,000       0.90       -    
4/12/2015
      13,500  
05/18/12
    350,000       0.95       -    
5/18/2015
      332,500  
06/28/12
    (5,299,002 )     0.55       -       -       (2,914,451 )
06/28/12
    3,179,410       1.20       5    
06/28/17
      3,815,292  
Expired
    (617,530 )     0.78       -       -       (488,525 )
Balance 6/30/12
    25,484,789       0.93       -       -       23,727,313